Edition:
India

Albireo Pharma Inc (ALBO.OQ)

ALBO.OQ on NASDAQ Stock Exchange Capital Market

24.82USD
7 Aug 2020
Change (% chg)

$-0.01 (-0.04%)
Prev Close
$24.83
Open
$24.84
Day's High
$25.42
Day's Low
$24.62
Volume
62,784
Avg. Vol
36,780
52-wk High
$31.28
52-wk Low
$11.26

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2020 Jun '20 1.91 -1.375
Mar '20 1.55 -2.228
FY 2019 Dec '19 6.43 -0.592
Sep '19 1.38 -1.727
Jun '19 1.25 -1.346
Mar '19 0.57 -1.388
FY 2018 Dec '18 0.57 -1.325
Sep '18 0.24 -1.172
Jun '18 0.73 -1.223
Mar '18 11.20 -0.149
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-20 7 1.29 1.75 0.00 0.00
Quarter Ending Dec-20 7 1.98 6.00 0.00 0.00
Year Ending Dec-20 7 6.05 10.90 1.55 14.96
Year Ending Dec-21 8 17.36 35.52 4.00 45.34
Earnings (per share)
Quarter Ending Sep-20 8 -1.62 -1.21 -1.83 -1.25
Quarter Ending Dec-20 8 -1.77 -1.40 -2.95 -1.19
Year Ending Dec-20 8 -7.24 -6.31 -8.84 -5.37
Year Ending Dec-21 8 -6.33 -4.42 -8.55 -4.57
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Albireo Pharma Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -4.27 -7.57 25 --
13 Week -12.00 -16.29 28 --
26 Week -7.54 -14.56 42 --
52 Week 48.07 25.50 77 --
YTD 25.27 10.01 64 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 77.58%
# of Holders: 121
Total Shares Held: 11,621,766
3 Mo. Net Change: -15,915
# New Positions: 8
# Closed Positions: 2
# Increased Positions: 20
# Reduced Positions: 12
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.